MedTech Dive April 2, 2025
Medtronic, Abbott and Boston Scientific had updates on their devices used in heart valve disease treatment at the event.
Research evaluating technologies to treat heart valve disease was a highlight of the American College of Cardiology’s annual conference, which wrapped up Monday in Chicago.
Here are updates from three studies that focused on devices used in valve treatment from some of medtech’s biggest companies:
1. Medtronic’s Evolut outcomes similar to surgery
Patients who received Medtronic’s Evolut transcatheter aortic valve replacement had rates of death or disabling stroke at five years that were comparable to those treated with a surgically implanted valve, data presented Sunday showed.
Minimally invasive TAVR has surpassed open-heart surgery as the preferred procedure for aortic valve...
Today's Sponsors
Today's Sponsor